Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lyell Immunopharma Inc (NQ: LYEL ) 1.700 +0.120 (+7.59%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lyell Immunopharma Inc < Previous 1 2 3 Next > Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial June 26, 2024 Lyell Immunopharma shares fell following the release of initial clinical data from its Phase 1 trial of LYL797, a reprogrammed CAR T-cell product. The company reported some severe cases reported in... Via Benzinga Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology June 26, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference June 03, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Why Lyell Immunopharma Shares Are Rising Today November 10, 2023 Lyell Immunopharma, Inc. (NASDAQ: LYEL) shares are trading higher after the company announced that the U.S. Via Benzinga Lyell Immunopharma to Participate in BofA Securities Health Care Conference May 07, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024 May 06, 2024 LYEL stock results show that Lyell Immunopharma beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024 May 06, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session April 16, 2024 U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session April 12, 2024 Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. Via Benzinga Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday April 12, 2024 U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday’s session as the company reported better-than-expected... Via Benzinga Topics Stocks Exposures US Equities Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday April 12, 2024 Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session April 11, 2024 Via Benzinga BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday April 09, 2024 U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. Via Benzinga Topics Stocks Exposures US Equities Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free Via Benzinga Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting March 05, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday March 04, 2024 U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Via Benzinga Topics Stocks Exposures US Equities Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023 February 28, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma Announces Participation in March Investor Conferences February 26, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 02, 2024 Shares of Longboard Pharmaceuticals, Inc. Via Benzinga Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 14, 2023 Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session November 10, 2023 Via Benzinga Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session November 10, 2023 Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. Via Benzinga Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma November 09, 2023 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023 November 07, 2023 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL Manufacturing October 31, 2023 Six presentations highlight innovations designed to shorten TIL manufacturing, new nonclinical data on LYL119, new technologies and clinical trials in progress From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting September 27, 2023 Presentations to highlight new nonclinical data on product candidates, new technologies, innovations designed to shorten TIL manufacturing and clinical trials in progress From Lyell Immunopharma, Inc Via GlobeNewswire Cellares and Lyell to Evaluate Automated Manufacturing of Lyell’s CAR T-Cell Therapy on Cellares’ Cell Shuttle Platform September 11, 2023 From Lyell Immunopharma, Inc; Cellares Via GlobeNewswire Lyell Immunopharma to Participate in Upcoming Investor Conferences August 31, 2023 From Lyell Immunopharma, Inc Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023 August 28, 2023 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.